Sponsors

RECENT NEWS

Improving blood culture diagnostics across the NHS

IBMS, BD and PLMR Healthcomms have released a new report which highlights the need for more consistent and collaborative approaches to reduce contamination rates, improve diagnostic accuracy and enhance patient care.

BioSkryb Genomics and Tecan introduce a single-cell multiomics

BioSkryb Genomics and Tecan Group have introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser, provided by Tecan.

New guidance for managing assay performance

IBMS, LabMed and RCPath have collaborated to set out a shared position on how UK laboratories can improve oversight, clarify accountability and take a whole-system approach to managing assay performance.

Blood proteins can predict liver disease up to 16 years before symptoms

Research scientists have identified five specific blood proteins that can accurately predict a person’s risk for developing a serious form of liver disease as early as 16 years before they experience symptoms, enabling early intervention and possible prevention and treatment, according to a study to be presented at Digestive Disease Week.

UK research network to unlock gut, immune and brain health links

A groundbreaking UK research network has been launched to uncover how gut health influences the brain, immune system and mental wellbeing. The project will run for four years and has received £4.5 million in funding from the Biotechnology and Biological Sciences Research Council (BBSRC).

PredxBio and Hamamatsu to deliver next-generation spatial biology solutions

PredxBio, a pioneer in AI-powered spatial biomarker discovery, is to partner with Hamamatsu to deliver next-generation spatial biology solutions for cancer research and therapeutic development.

Partnership to integrate sequencing and analysis platforms

Complete Genomics, a leading innovator in genomic sequencing, has announced a collaboration with Velsera, a leading global healthcare technology company, to deliver an end-to-end genetic testing solution that integrates DNBSEQ sequencing technology with Velsera's Clinical Genomics Workspace (CGW) data analysis solution.

Gestalt Raises $7.5 million to develop AI pathology

Gestalt, a leading innovator in AI-powered digital pathology solutions, has raised $7.5 million Series A financing to further develop its AI-powered pathology platform, PathFlow.

Sophia Genetics and AstraZeneca expand liquid biopsy partnership

Medtech firm Sophia Genetics is to expand its ongoing collaboration with AstraZeneca to accelerate the deployment of MSK-ACCESS liquid biopsy application.

Roche’s AI-driven companion diagnostic for non-small cell lung cancer designated ‘Breakthrough Device’

Roche has announced today that the US Food and Drug Administration (FDA) granted Breakthrough Device Designation for the VENTANA TROP2 (EPR20043) RxDx Device. This is the first Breakthrough Device Designation to be granted for a computational pathology companion diagnostic (CDx) device.

AnalytiChem introduces Redipor ready-to-use culture media globally

AnalytiChem, manufacturer of laboratory equipment, reagents and consumables, has introduced Redipo, a new range of ready-to-use culture media.

NHS Wales to trial AI-assisted pathology

Paige, together with NHS Wales, has announced the launch of a new pilot project at Betsi Cadwaladr University Health Board (BCUHB). The project will evaluate how Paige’s AI-assisted diagnostic application, Paige PanCancer Detect, can streamline pathology workflows and enhance patient care by triaging routine clinical cases.

UKHSA publishes mpox strategy

The UK Health Security Agency (UKHSA), has just published an overarching public health strategy for controlling and eliminating mpox (previously referred to as monkeypox) across the UK, focusing on the next 12-month period.

Novel cancer blood test set for UK clinical trial

In collaboration with the National Institute for Health and Care Research (NIHR), the UK government has awarded £2.4 million to progress the development of a novel AI-driven blood test, known as miONCO-Dx.

New instrument automates density gradient preparation

Beckman Coulter Life Sciences has launched the OptiMATE Gradient Maker, a groundbreaking instrument designed to automate the process of density gradient ultracentrifugation (DGUC).

Integrative approach boosts Alzheimer’s gene research

A new study provides solutions to the pressing need to identify factors that influence Alzheimer’s disease (AD) risk or resistance while providing an avenue to explore potential biological markers and therapeutic targets.

​AMR-related infections caused over 3 million child deaths in 2022

A landmark study presented at ESCMID Global 2025 has revealed that over 3 million children worldwide lost their lives in 2022 due to antimicrobial resistance (AMR)-related infections.

£9 million investment fuels groundbreaking bioscience research

UK Research and Innovation’s Biotechnology and Biological Sciences Research Council (BBSRC) has announced £9 million in funding for a variety of bioscience projects, with its prestigious 2024 Fellowships scheme supporting 19 future science leaders

Roche announces US investment in diagnostics

Roche has announced an investment of US $50 billion into the United States of America in the next five years across its pharmaceutical and diagnostics divisions.

ARUP launches pTau 217 blood test to detect Alzheimer's

ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in patients ages 60 years and older are related to Alzheimer's disease (AD) pathology.

Latest Issues

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025